131 results
Page 2 of 7
6-K
EX-99.4
vzw6ex700e1jw httw
18 Aug 21
RepliCel Life Sciences Announces Closing of Debt Settlement
12:34pm
6-K
EX-99.5
sjuah27
18 Aug 21
Current report (foreign)
12:20pm
20-F/A
ahx8ne2addu
31 Mar 21
Annual report (foreign) (amended)
12:00am
6-K
EX-99.4
96yky0uzww 4fjgpja
3 Feb 21
RepliCel and MainPointe Pharmaceuticals Sign Strategic Investment and Collaboration Agreement
12:03pm
6-K
EX-99.3
zglic76 r4ccpj
3 Feb 21
RepliCel and MainPointe Pharmaceuticals Sign Strategic Investment and Collaboration Agreement
12:03pm
6-K
EX-99.5
e080j8 v1
3 Feb 21
RepliCel and MainPointe Pharmaceuticals Sign Strategic Investment and Collaboration Agreement
12:03pm
6-K
EX-99.2
moh259yvjo9qug ur
22 Dec 20
Current report (foreign)
3:05pm
6-K
EX-99.1
nlbc0guurhfykh2tc
30 Nov 20
Condensed Consolidated Interim Financial Statements
5:19pm
6-K
EX-99.2
t7n8qy c2tqf1s
30 Nov 20
RepliCel Announces Filing of Amended and Restated Financial Statements and Management Discussion & Analysis
10:05am
6-K
EX-99.1
3lfv j4naoopfj6
30 Nov 20
RepliCel Announces Filing of Amended and Restated Financial Statements and Management Discussion & Analysis
10:05am
6-K
EX-99.1
4af3d3nczsi
13 Nov 20
Notice of Annual General and Special Meeting of Shareholders
12:00am
6-K
EX-99.1
idftshm4
15 Oct 20
Condensed Consolidated Interim Financial Statements
5:15pm
6-K
EX-99.1
6m0 t1y1940902v56u
3 Aug 20
Consolidated Financial Statements
12:00am
6-K
EX-99.1
ln3k3j1 t4homlt
31 Jul 20
Condensed Consolidated Interim Financial Statements
9:14pm
6-K
EX-99.1
zf6vo1u48xslpspe
6 Nov 19
Notice of Annual General and Special Meeting of Shareholders
12:00am